A novel anti-inflammatory role for ginkgolide B in asthma via inhibition of the ERK/MAPK signaling pathway

Molecules

Volumn 16, Issue 9, 2011, Pages 7634-7648

  Chu, Xiao ^a   Ci, Xinxin ^a   He, Jiakang ^b   Wei, Miaomiao ^a   Yang, Xiaofeng ^a   Cao, Qingjun ^a   Li, Hongyu ^a   Guan, Shuang ^a   Deng, Yanhong ^a   Pang, Daxin ^a   Deng, Xuming ^a  

^a JILIN UNIVERSITY   (China)

^b GUANGXI UNIVERSITY   (China)

Author keywords

Airway hyper responsiveness; Airway inflammation; Asthma; Ginkgolide B; MAPK

Indexed keywords

ANTIINFLAMMATORY AGENT; CYTOKINE; GINKGOLIDE; GINKGOLIDE B; IMMUNOGLOBULIN E; INTERLEUKIN 13; INTERLEUKIN 5; LACTONE; MITOGEN ACTIVATED PROTEIN KINASE; OVALBUMIN;

ANIMAL; ARTICLE; ASTHMA; BLOOD; CELL COUNT; CHEMISTRY; CYTOLOGY; DRUG ANTAGONISM; DRUG EFFECT; EOSINOPHIL; FEMALE; GOBLET CELL; HYPERPLASIA; IMMUNOLOGY; INFLAMMATION; LUNG; LUNG LAVAGE; MACROPHAGE; METABOLISM; MOUSE; NEUTROPHIL; PATHOLOGY; SECRETION; SIGNAL TRANSDUCTION;

ANIMALS; ANTI-INFLAMMATORY AGENTS; ASTHMA; BRONCHOALVEOLAR LAVAGE FLUID; CELL COUNT; CYTOKINES; EOSINOPHILS; FEMALE; GINKGOLIDES; GOBLET CELLS; HYPERPLASIA; IMMUNOGLOBULIN E; INFLAMMATION; INTERLEUKIN-13; INTERLEUKIN-5; LACTONES; LUNG; MACROPHAGES; MAP KINASE SIGNALING SYSTEM; MICE; MITOGEN-ACTIVATED PROTEIN KINASES; NEUTROPHILS; OVALBUMIN;

EID: 80053224180     PISSN: None     EISSN: 14203049     Source Type: Journal    
DOI: 10.3390/molecules16097634     Document Type: Article

References (36)

1. Bloemen, K.; Verstraelen, S.; van Den Heuvel, R.; Witters, H.; Nelissen, I.; Schoeters, G. The allergic cascade: Review of the most important molecules in the asthmatic lung. Immunol. Lett. 2007, 113, 6-18. (Pubitemid 47464616)
2. Brightling, C.E.; Symon, F.A.; Birring, S.S.; Bradding, P.; Pavord, I.D.; Wardlaw A.J. TH2 cytokine expression in bronchoalveolar lavage fluid T lymphocytes and bronchial submucosa is a feature of asthma and eosinophilic bronchitis. J. Allergy Clin. Immunol. 2002, 110, 899-905. (Pubitemid 36005878)
3. Sanderson, C.J. Interleukin-5, eosinophils, and disease. Blood 1992, 79, 3101-3109.
4. Simon, D.; Braathen, L.R.; Simon, H.U. Eosinophils and atopic dermatitis. Allergy 2004, 59, 561-570. (Pubitemid 38748052)
5. Lopez, A.F.; Sanderson, C.J.; Gamble, J.R.; Campbell, H.D.; Young, I.G.; Vadas, M.A. Recombinant human interleukin 5 is a selective activator of human eosinophil function. J. Exp. Med. 1988, 167, 219-224. (Pubitemid 18093705)
6. Umetsu, D.T.; DeKruyff, R.H. TH1 and TH2 CD4+ cells in human allergic diseases. J. Allergy Clin. Immunol. 1997, 100, 1-6. (Pubitemid 27328523)
7. Wills-Karp, M.; Luyimbazi, J.; Xu, X.; Schofield, B.; Neben, T.Y.; Karp, C.L.; Donaldson, D.D. Interleukin-13: Central mediator of allergic asthma. Science 1998, 18, 2258-2261. (Pubitemid 29004074)
8. Hershey, G.K. IL-13 receptors and signaling pathways: An evolving web. J. Allergy Clin. Immunol. 2003, 111, 677-690. (Pubitemid 36470232)
9. Hu, L.; Chen, Z.; Xie, Y.; Jiang, Y.; Zhen, H. Alkyl and alkoxycarbonyl derivatives of ginkgolide B: Synthesis and biological evaluation of PAF inhibitory activity. Bioorg. Med. Chem. 2000, 822, 1515-1521. (Pubitemid 30398470)
10. Hsuuw, Y.D.; Kuo, T.F.; Lee, K.H.; Liu, Y.C.; Huang, Y.T.; Lai, C.Y.; Chan, W.H. Ginkgolide B Induces Apoptosis via Activation of JNK and p21-Activated Protein Kinase 2 in Mouse Embryonic Stem Cells. Ann. N.Y. Acad. Sci. 2009, 1171, 501-508.
11. Muntaner, O.; Pedruzzi, E.; Roch-Arveiller, M.; Tissot, M.; Drieu, K.; Périanin, A. Ginkgolide B stimulates signaling events in neutrophils and primes defense activities. Biochem. Biophys. Res. Commun. 2005, 335, 1149-1154. (Pubitemid 41215538)
12. Tosaki, A.; Engelman, D.T.; Pali, T.; Engelman, R.M.; Droy-Lefaix, M.T. Ginkgo biloba extract (EGb 761) improves postischemic function in isolated preconditioned working rat hearts. Coronary Artery Dis. 1994, 5, 443-450. (Pubitemid 24222649)
13. Johnson, G.L.; Lapadat, R. Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases. Science 2002, 298, 1911-1912. (Pubitemid 35425238)
14. Tsang, F.; Koh, A.H.; Ting, W.L.; Wong, P.T.; Wong, W.S. Effects of mitogen-activated protein kinase inhibitor PD 098059 on antigen challenge of guinea-pig airways in vitro. Br. J. Pharmacol. 1998, 25, 61-68. (Pubitemid 28418757)
15. Tosaki, A.; Pali, T.; Droy-Lefaix, M.T. Effects of Ginkgo biloba extract and preconditioning on the diabetic rat myocardium. Diabetologia 1996, 39, 1255-1262. (Pubitemid 26356051)
16. Haines, D.D.; Varga, B.; Bak, I.; Juhasz, B.; Mahmoud, F.F.; Kalantari, H.; Gesztelyi, R.; Lekli, I.; Czompa, A.; Tosaki, A. Summative interaction between astaxanthin, Ginkgo biloba extract (EGb761) and vitamin C in suppression of respiratory inflammation: a comparison with ibuprofen. Phytother. Res. 2011, 25, 128-136.
17. Tosaki, A.; Droy-Lefaix, M.T.; Pali, T.; Das, D.K. Effects of SOD, catalase, and a novel antiarrhythmic drug, EGB 761, on reperfusion-induced arrhythmias in isolated rat hearts. Free Radic. Biol. Med. 1993, 14, 361-370. (Pubitemid 23087399)
18. Sanderson, C.J. Interleukin-5, eosinophils, and disease. Blood 1992, 79, 3101-3109.
19. Dewson, G.; Cohen, G.M.; Wardlaw, A.J. Interleukin-5 inhibits translocation of Bax to the mitochondria, cytochrome c release, and activation of caspases in human eosinophils. Blood 2001, 98, 2239-2247.
20. Sher, A.; Coffman, R.L.; Hieny, S.; Cheever, A.W. Ablation of eosinophil and IgE responses with anti-IL-5 or anti-IL-4 antibodies fails to affect immunity against Schistosoma mansoni in the mouse. J. Immunol. 1990, 145, 3911-3916.
21. Horie, S.; Okubo, Y.; Hossain, M.; Sato, E.; Nomura, H.; Koyama, S.; Suzuki, J.; Isobe, M.; Sekiguchi, M. Interleukin-13 but not interleukin-4 prolongs eosinophi survival and induces eosinophil chemotaxis. Internal Med. 1997, 36, 179-185. (Pubitemid 27249724)
22. Schleimer, R.P.; Sterbinsky, S.A.; Kaiser, J.; Bickel, C.A.; Klunk, D.A.; Tomioka, K.; Newman, W.; Luscinskas, F.W.; Gimbrone, M.A., Jr.; McIntyre, B.W. IL-4 induces adherence of human eosinophils and basophils but not neutrophils to endothelium. Association with expression of VCAM-1. J. Immunol. 1992, 148, 1086-1092.
23. Green, R.H.; Brightling, C.E.; McKenna, S.; Hargadon, B.; Parker, D.; Bradding, P.; Wardlaw, A.J.; Pavord, I.D. Asthma exacerbations and sputum eosinophil counts: A randomized controlled trial. Lancet 2002, 360, 1715-1721. (Pubitemid 35447900)
24. Sont, J.K.; Willems, L.N.; Bel, E.H.; van Krieken, J.H.; Vandenbroucke, J.P.; Sterk, P.J. Clinical control and histopathologic outcome of asthma when using airway hyper-responsiveness as an additional guide to long-term treatment. Am. J. Respir. Crit. Care Med. 1999, 159, 1043-1051. (Pubitemid 29202534)
25. Vargaftig, B.B.; Singer, M. Leukotrienes mediate murine bronchopulmonary hyperreactivity, inflammation, and part of mucosal metaplasia and tissue injury induced by recombinant murine interleukin-13. Am. J. Respir. Cell Mol. Biol. 2003, 28, 410-419. (Pubitemid 36399362)
26. Gleich, G.J. Mechanisms of eosinophil-associated inflammation. J. Allergy Clin. Immunol. 2000, 105, 651-663. (Pubitemid 30226437)
27. Hamelmann, E.; Tadeda, K.; Oshiba, A.; Gelfand, E.W. Role of IgE in the development of allergic airway inflammation and airway hyper-responsiveness in a murine model. Allergy 1999, 54, 297-305. (Pubitemid 29232384)
28. Holgate, S.; Casale, T.; Wenzel, S.; Bousquet, J.; Deniz, Y.; Reisner, C. The anti-inflammatory effects of omalizumab confirm the central role of IgE in allergic inflammation. J. Allergy Clin. Immunol. 2005, 115, 459-465. (Pubitemid 40341694)
29. Nel, A.E. T-cell activation through the antigen receptor. Part 1: Signaling components, signaling pathways, and signal integration at the T-cell antigen receptor synapse. J. Allergy Clin. Immunol. 2002, 109, 758-770. (Pubitemid 34499506)
30. Jacob, A.; Cooney, D.; Pradhan, M.; Coggeshall, K.M. Convergence of signaling pathways on the activation of ERK in B cells. J. Biol. Chem. 2002, 277, 23420-23426. (Pubitemid 34952174)
31. Gauld, S.B.; Dal Porto, J.M.; Cambier, J.C. B cell antigen receptor signaling: Roles in cell development and disease. Science 2002, 296, 1641-1642. (Pubitemid 34579149)
32. Nadler, M.J.; Matthews, S.A.; Turner, H.; Kinet, J.P. Signal transduction by the high-affinity immunoglobulin E receptor FcεRI: coupling form to function. Adv. Immunol. 2000, 76, 325-355. (Pubitemid 33717331)
33. Kumar, A.; Lnu, S.; Malya, R.; Barron, D.; Moore, J.; Corry, D.B.; Boriek, A.M. Mechanical stretch activates nuclear factor-κB, activator protein-1, and mitogen-activated protein kinases in lung parenchyma: implications in asthma. FASEB J. 2003, 17, 1800-1811. (Pubitemid 37214774)
34. Duan, W.; Chan, J.H.; Wong, C.H.; Leung, B.P.; Wong, W.S. Anti-inflammatory effects of mitogen-activated protein kinase kinase inhibitor U0126 in an asthma mouse model. J. Immunol. 2004, 172, 7053-7059. (Pubitemid 38669147)
35. Bao, Z.; Lim, S.; Liao, W.; Lin, Y.; Thiemermann, C.; Leung, B.P.; Wong, W.S. Glycogen synthase kinase-3beta inhibition attenuates asthma in mice. Am. J. Respir. Crit. Care Med. 2007, 176, 431-438. (Pubitemid 47358096)
36. Towbin, H.; Staehelin, T.; Gordon, J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: Procedure and some applications. Biotechnology 1992, 24, 145-149.